"The new complexes of Cr(III), Mn (II), Fe(III) and Cu(II) complexes with the chalcone ligand were studied on the growth of Rhabdomyo sarcomas (RD) cell Line in human by using in vitro system and compared with anticancer drug cis-platin (cis-pt) as appositive control. The cancer cells were treated with different concentration and cis-pt after 72 hr. exposure time. The cytotoxic activity was tested by inhibition rate as parameter. The results showed significant differences (p<0.05) for each three treatments when the inhibition rates were increased. The synthesized compounds were tested for antimicrobial activity by cup plate diffusion method. The results indicate the enhanced activity of metal complexes over the parent ligands. The synthesized complexes have been screened for in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus, and new prepared complexes were compared with anticancer drug cis-platin."
Published in | Journal of Cancer Treatment and Research (Volume 5, Issue 3) |
DOI | 10.11648/j.jctr.20170503.12 |
Page(s) | 39-42 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Chalcone, Complexes, Antimicrobial Activity, Cytotoxicity Cisplatin
[1] | A. W. Star, and T. J. Marby, Phytochemistry, 10, 2812 (1971). |
[2] | D. N. Dhar, Wiley, 213 (1981). |
[3] | K. Satyanarayana and M. N. A. Rao., Indian Drugs, 30.313 (1993). |
[4] | T. Torigoo, M. Arisawa, S. IIoch, M. Fujiu and H. B. Mayuyama, Biochem. Biophys. Res. Commun., 112, 833. |
[5] | M. L. Go, X. Wu and X. L. Liu, Current. Medicinal. Chemistry, 12, 483 (2005). |
[6] | Young Hoon Kim, Jeongsoo Kim, Haeil Park, Hyun Pyo Kim, Biol. Pharm. Bull, 30 (80), pp 1450-1455, (2007). |
[7] | W. Shen Jeu, L. Cheng Tsung, T. Lo Ti, W. Jing Ru, K. Hrogn Huey, W. Jih Pyang and L. |
[8] | Chun Nan, Eur. J. Med. Chem., 40, 103 (2005). |
[9] | N. Liming, W. J. Kimberly, M. Weingarten and S. A. Janes, PCT Int. Appl., 411 (2003). |
[10] | E. Francesco, G. Salvatore, M. Luigi and C. Massimo, Phytochem, 68, 939 (2007). |
[11] | S. Ducki, R. Forrest, J. A. Hadfield, A. Kendall, N. J. Lawrence, A. T. Mc Gown and D. |
[12] | Rennson, Bioorg. Med. Chem. Lett., 8, 1051 (1998). |
[13] | E. Bombardelli, and P. Valenti, PCT Int. Appl., 18 (1998). |
[14] | M. Chen, T. G. Theander, S. B. Christensen, L. Hrlid, Zhai and A. Kharazmi, Antimicrob. Agents. Chemother, 38, 1470 (1994). |
[15] | J. C. Onyilagha, B. Malhotra, M. Elder and G. H. N. Towers, Can. J. Plant. Pathol, 19, 133 (1997). |
[16] | H. X. Xu, M. Wan, H. Dong, P. But and L. Y. Foo, Biol. Pharm. Bull., 23, 1072 (2000). |
[17] | Omar H. Al-Obaidi,” Synthesis, Spectral Characterization, Theoretical Evaluation Of New Cr (III), Co (II), Fe(III) And Cu(II) Complexes”, App. Sci. Report., 12 (1), 2015: 41-45. And Saad M. Mahdi, Russel I. Aliway,” Preparation and identification of a new azo-chalcone ligand (VACAN) and its complexes with some divalent transition metal ions’, Iraqi National Journal of Chemistry 2015; 15 (2). |
[18] | Freshney, R. I., “Cultured of Animal Cells: A manual for Basic Techniques “, Inc. Publication, New York, pp 64-69, 2000. And El-Sayed YS, Gaber M. “Studies on chalcone derivatives: complex formation, thermal behavior, stability constant and antioxidant activity Spectrochim Acta A Mol Biomol Spectrosc. (2015); 137: 423-31. |
[19] | Gao, X., Xu, X., Janakiraman, N., Gautam, S. C., “Disparate in vivo Antileukemic Effect of Reserveratol a Natural Polyphenolic Compound Found in Grapes”, Nutr.., 132, pp 2076-2081, 2002. |
[20] | Vandpitte J., et al. (1991), "Basic laboratory procedures in clinical bacteriology "WHO, Genevap. pp 78-110). |
[21] | Birt, F. D, Hendrich, S, Wang, W., “Dietary Agents in Cancer Prevention Flavonoids and Isoflavonoids Pharmacology and Therapeutics”, USA, pp 157-177, 2001. |
[22] | Tsuda, S., Matsusaka, N., Madaram H., Ueno, S., Susa, N., Ishida, K., Kawamura, N., Sekihashi, K., Sasak, Y., “the Comet Assay in Eight Mouse Organs Results with 2 Azo Compounds”, Mutat. Res., 465, pp 1139-1151, 2000. |
[23] | Kenyon, G., Puja, G., Harbach, R., Wayne, G., Ping Dou, Q., “Organic Copper Complexes as new Class of Proteasome Inhibitors and Apoptosis Inducers in Human Cancer Cells,” Bioc. Pharm. 67, pp 1139-1151, 2004. |
[24] | Saadiyah, A. D., Jinan H., and Iman H., J. of Al-Nahrain Univ., 15 (2), pp 23-28, 2012. |
[25] | Stordal B., Davey, M.,” Vander Standing cisplatin Resistance Using Cellular Models”, IUBMB Life, 59, pp 696-9, 2007. |
[26] | Y. Anjaneyalu, R. P. Rao, Synth. React. Inorg.-Org. chem. 16, 1986, pp. 257. |
[27] | L. Mishra, V. H. Singh, Indian J. Chem. 32A, 1993, pp. 446. |
[28] | S. Sumathi, P. Tharmaraj, C. D. Sheela, R. Ebenezer, “Synthesis, spectral, bioactivity, and NLO properties of chalcone metal complexes”, Journal of Coordination Chemistry 64 (10): 1707-1717. 2011. |
APA Style
Omar H. Al-Obaidi. (2017). Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity. Journal of Cancer Treatment and Research, 5(3), 39-42. https://doi.org/10.11648/j.jctr.20170503.12
ACS Style
Omar H. Al-Obaidi. Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity. J. Cancer Treat. Res. 2017, 5(3), 39-42. doi: 10.11648/j.jctr.20170503.12
AMA Style
Omar H. Al-Obaidi. Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity. J Cancer Treat Res. 2017;5(3):39-42. doi: 10.11648/j.jctr.20170503.12
@article{10.11648/j.jctr.20170503.12, author = {Omar H. Al-Obaidi}, title = {Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity}, journal = {Journal of Cancer Treatment and Research}, volume = {5}, number = {3}, pages = {39-42}, doi = {10.11648/j.jctr.20170503.12}, url = {https://doi.org/10.11648/j.jctr.20170503.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jctr.20170503.12}, abstract = {"The new complexes of Cr(III), Mn (II), Fe(III) and Cu(II) complexes with the chalcone ligand were studied on the growth of Rhabdomyo sarcomas (RD) cell Line in human by using in vitro system and compared with anticancer drug cis-platin (cis-pt) as appositive control. The cancer cells were treated with different concentration and cis-pt after 72 hr. exposure time. The cytotoxic activity was tested by inhibition rate as parameter. The results showed significant differences (p<0.05) for each three treatments when the inhibition rates were increased. The synthesized compounds were tested for antimicrobial activity by cup plate diffusion method. The results indicate the enhanced activity of metal complexes over the parent ligands. The synthesized complexes have been screened for in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus, and new prepared complexes were compared with anticancer drug cis-platin."}, year = {2017} }
TY - JOUR T1 - Study of the Cytotoxicity Effect of New Cr(III), Mn(II), Fe(III) and Cu(II) Complexes of Chalcone on Cancer (Cell Line RD) and Antimicribial Activity AU - Omar H. Al-Obaidi Y1 - 2017/03/27 PY - 2017 N1 - https://doi.org/10.11648/j.jctr.20170503.12 DO - 10.11648/j.jctr.20170503.12 T2 - Journal of Cancer Treatment and Research JF - Journal of Cancer Treatment and Research JO - Journal of Cancer Treatment and Research SP - 39 EP - 42 PB - Science Publishing Group SN - 2376-7790 UR - https://doi.org/10.11648/j.jctr.20170503.12 AB - "The new complexes of Cr(III), Mn (II), Fe(III) and Cu(II) complexes with the chalcone ligand were studied on the growth of Rhabdomyo sarcomas (RD) cell Line in human by using in vitro system and compared with anticancer drug cis-platin (cis-pt) as appositive control. The cancer cells were treated with different concentration and cis-pt after 72 hr. exposure time. The cytotoxic activity was tested by inhibition rate as parameter. The results showed significant differences (p<0.05) for each three treatments when the inhibition rates were increased. The synthesized compounds were tested for antimicrobial activity by cup plate diffusion method. The results indicate the enhanced activity of metal complexes over the parent ligands. The synthesized complexes have been screened for in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus, and new prepared complexes were compared with anticancer drug cis-platin." VL - 5 IS - 3 ER -